Company Filing History:
Years Active: 2022
Title: Hiromitsu Umeno: Innovator in RNA Mutation Technology
Introduction
Hiromitsu Umeno is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of molecular biology, particularly in the area of RNA mutation technology. His innovative methods have the potential to advance genetic research and therapeutic applications.
Latest Patents
Umeno holds a patent for a method that introduces site-directed RNA mutations. This patent, titled "Method for introducing site-directed RNA mutation, target editing guide RNA used in the method and target RNA-target editing guide RNA complex," describes a process for repairing RNA mutations. The method involves converting target adenosine, located at a target editing site of a target RNA, into inosine. By utilizing a target editing guide that forms a complementary strand with the target RNA, Umeno's method enables the conversion of adenosine to inosine through the action of ADAR on a double-stranded complex, ultimately facilitating A-to-I editing capability.
Career Highlights
Hiromitsu Umeno is affiliated with Fukuoka University, where he conducts research and develops innovative solutions in the field of RNA technology. His work has garnered attention for its potential applications in genetic editing and therapeutic interventions.
Collaborations
Umeno collaborates with Masatora Fukuda, contributing to advancements in RNA mutation techniques and enhancing the scope of their research.
Conclusion
Hiromitsu Umeno's contributions to RNA mutation technology exemplify the innovative spirit of modern science. His patented methods hold promise for future developments in genetic research and therapy.